The role of antidepressant treatments on cognitive deficits a review of recent literature

Clinical Neuropsychiatry

Volumn 8, Issue 6, 2011, Pages 354-366

  Francomano, Antonio ^a   Bonanno, Barbara ^a   Fucà, Laura ^a   la Placa, Maddalena ^a   la Barbera, Daniele ^a  

^a UNIVERSITY OF PALERMO   (Argentina)

Author keywords

Antidepressants; Cognition; Major depressive disorder; Neuropsychology

Indexed keywords

AMFEBUTAMONE; ANTIDEPRESSANT AGENT; CITALOPRAM; DULOXETINE; ESCITALOPRAM; FLUOXETINE; FLUVOXAMINE; NORTRIPTYLINE; PAROXETINE; PLACEBO; REBOXETINE; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; SERTRALINE;

ARTICLE; ATTENTION; CASE CONTROL STUDY; COGNITIVE DEFECT; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG EFFECT; DRUG EFFICACY; DRUG TOLERABILITY; EARLY INTERVENTION; EPISODIC MEMORY; EXECUTIVE FUNCTION; HAMILTON SCALE; HUMAN; JOB PERFORMANCE; LIFE STRESS; MAJOR DEPRESSION; MEMORY DISORDER; MENTAL FUNCTION; MINI MENTAL STATE EXAMINATION; NEUROPROTECTION; PRODUCTIVITY; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REMISSION; SPATIAL MEMORY; SYSTEMATIC REVIEW; VERBAL MEMORY; VISUAL MEMORY; WECHSLER INTELLIGENCE SCALE; WORKING MEMORY;

EID: 84856980732     PISSN: 17244935     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (79)

1. American Psychiatric Association (1994). Diagnostic and Statistical Manual of Mental Disorders, 4th ed. American Psychiatric Association, Washington, DC.
2. Andreani O, Amoretti G, Baldi P (1990). Manuale del MLT'88. Organizzazioni Speciali, Firenze.
3. Beck AT (1967). Depression: Causes and treatment. Hoeber, New York. Republished as Depression: Causes and treatment. University of Pennsylvania Press, Philadelphia.
4. Benton AL, Sivan AB, Hamsher K, Varney NR, Spreen O (1983). Contribution to neuropsychological assessment. Oxford University Press, NY.
5. Borrini G, Dall'Ora P, Della Sala S, Marinelli L, Spinnler H (1989). Autobiographical memory. Sensitivity to age and education of a standardized enquiry. Psychol Med 19, 215-224.
6. Brugha TS, Bebbington PE, Tennant C, Hurry J (1985). Psychological Medicine 15, 189-194.
7. Buschke H, Fuld P (1974). Evaluating storage, retention and retrieval in disordered memory and learning. Neurology 24, 1019-1025.
8. Calabrese F, Molteni R, Maj PF, Cattaneo A, Gennarelli M, Racagni G, Riva MA (2007). Chronic duloxetine treatment induces specific changes in the expression of BDNF transcripts and in the subcellular localization of the neurotrophin protein. Neuropsychopharmacology 32, 2351-2359
9. Calkins MA (1894). Paired Associated Learning (PAL).
10. Castaneda AE, Tuulio-Henriksson A, Marttunen M, Suvisaari J, Lonnqvist J (2008). A review on cognitive impairments in depressive and anxiety disorders with a focus on young adults. Journal of Affective Disorders 106, 1-27
11. Cegalis JA (1991). Vigil: software for testing concentration and attention, Manual. Forthought Ltd. Nashua, NH.
12. Cheng-Ta L, Ching-Po L, Kun-Hsien C, I-Yun C, Jen-Chuen H, Chia-Liang W, Wei-Chen L, Tung-Ping S (2010). Structural and cognitive deficits in remitting and non-remitting recurrent depression: a voxel-based morphometric study. Neuroimage 50, 347-356.
13. Clark L, Chamberlain SR, Sahakian BJ (2009). Neurocognitive mechanisms in depression: implication for treatment. Annu Rev Neurosci 32, 57-74.
14. Cooney RE, Joormann J, Atlas LY, Eugene F, Gotlib IH (2007). Remembering the good times: neural correlates of affect regulation. Neuroreport 18, 1771-74.
15. Conners CK. & MHS Staff (2000). Conner's continuous performance test II. Computer Program for Windows Technical Guide and Software Manual. Mutli-Health Systems, North Tonwanda, NY.
16. Culang ME, Sneed JR, Keilp JG, Rutherford BR, Pelton GH, Devanand DP, Roose SP (2009). Change in cognitive functioning following acute antidepressant treatment in late-life depression. Am J Geriatr Psychiatry 17, 10, 881-8.
17. Faglioni P, Cremonini AM, De Renzi E (1991). Taratura su sog- getti normali di test di facce sconosciute. Un contributo allo studio della Prosopagnosia. Arch Psicol Neurol Psichiatr 52, 3, 339-350.
18. First MB, Spitzer RL, Gibbon M, Williams JBW (1994). Structured clinical interview for DSM-IV axis I disorders (SCID). New York State Psychiatric Institute, Biometrics Research, New York.
19. Fossati P, Ergis AM, Allilaire JF (2002). Executive functioning in unipolar depression: a review. Encephale 28, 2, 97-107
20. Galassi R, Di Sarro R, Morreale A, Amore M (2006). Memory impairment in patients with late-onset major depression: The effect of antidepressant therapy. Journal of Affective Disorders 91, 2-3, 243-50.
21. Ghormley C, Basso M, Candlis P, Combs D (2011). Neuropsychological impairment corresponds with poor understanding of informed consent disclosures in persons diagnosed with major depression. Psychiatry Research 187, 106-112.
22. Golden CJ (1978). Stroop Colour and Word Test. A Manual for Clinical and Experimental Users. Stoelting Chicago, Illinois.
23. Gorlyn M, Keilp JG, Grunebaum MF, Bonnie PT, Oquendo MA, Bruder GE, Stewart JW, Zalsman G, Mann JJ (2008). Neuropsychological characteristics as predictors of SSRI treatment response in depressed subjects. J Neural Transm 115, 8, 1213-9.
24. Gorwood P, Corruble E, Falissard B, Goodwin GM (2008). Toxic Effects of Depression on Brain Function: Impairment of Delayed Recall and the Cumulative Length of Depressive Disorder in a Large Sample of Depressed Outpatients. Am J Psychiatry 165, 731-739.
25. Gotlib IH, Hamilton JP (2008). Neuroimaging and depression: current status and unresolved issues. Curr Dir Psychol Sci 17, 159-63.
26. Gotlib IH, Joormann J (2010). Cognition and depression: current status and future directions. Annu Rev Clin Psychol 27, 6, 285-312.
27. Graf P, Squire LR, Mandhler G (1984). The information that amnesic patients do not forget. J Exper Psychol Learn Mem Cogn 10, 164-168.
28. Gualtieri CT, LG Johnson, KB Benedict (2006). Neurocognition in Depression: Patients on and off Medication Versus Healthy Comparison Subjects. J Neuropsychiatry Clin Neurosci 18, 2, 217-225.
29. Guy W (1976). ECDEU assessment manual for psychopharmacology. Rev. Rockville, MD: U.S. National Institute of Health, Psychopharmacology Research Branch. [44 instruments] UTA location & call number: Central Library, Floor 2: US Government Pubs. HE 20.8108:P 93/2/976
30. Hamilton M (1960). A rating scale for depression. J Neurol Neurosurg Psychiatry 23, 56-62.
31. Hamilton M (1967). Development of a rating sale for primary depressive illness. Br JSoc Clin Psychol 6, 278-296.
32. Hamilton M (1967). Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol 6, 278-296.
33. Hasselbach BJ, Knorr U, Kessing LV (2010). Cognitive impairment in the remitted state of unipolar depressive disorder. A systematic review. J Affect Disord 14.
34. Heaton TH, McNutt M (1981). An evaluation of the sismic window theory. California Division of Mines and Geology, California Geology, pp. 12-16.
35. Herrmann LL, Goodwin GM, Ebmeier KP (2007). The cognitive neuropsychology of depression in the elderly. Psychol Med 37, 1693-1702
36. Herrera-Guzman I, Gudayol-Ferré E, Herrera-Guzman D, Guårdia-Olmos J, Hinojosa-Calvo E, Herrera-Abarca JE (2009). Effects of selective serotonin reuptake and dual serotonergic-noradrenergic reuptake treatments on memory and mental processing speed in patients with major depressive disorder. JPsychiatrRes 43, 9, 855-63.
37. Herrera-Guzman I, Herrera-Abarca JE, Gudayol-Ferré E, Herrera-Guzman D, Gomez-Carbajal L et al. (2010). Effects of selective serotonin reuptake and dual serotonergic-noradrenergic reuptake treatments on attention and executive functions in patients with major depressive disorder. Psychiatry Res 30, 177, 3, 323-9.
38. Herrera-Guzman I, Gudayol-Ferré E, Herrera-Abarca JE, Herrera-Guzman D, Montelongo-Pedraza P, Padros Blazquez F et al. (2010). Major Depressive Disorder in recovery and neuropsychological functioning: effects of selective serotonin reuptake inhibitor and dual inhibitor depression treatments on residual cognitive deficits in patients with Major Depressive Disorder in recovery. J Affect Disord 123, 1-3, 341-50.
39. Iverson GL, Brooks BL, Langenecker SA, Young AH (2011). Identifying a cognitive impairment subgroup in adults with mood disorders. J Affect Disord 24.
40. Keers R, Uher R, Bhanu G, et al. (2010). Stressful life events, cognitive symptoms of depression and response to antidepressants in GENDEP. J Affect Disord 127, 1-3, 33742.
41. Li CT, Lin CP, Chou KH (2010) Structural and cognitive deficits in remitting and non-remitting recurrent depression: a voxel-based morphometric study. Neuroimage 50, 1, 34756.
42. Lyche P, Jonassen R, Stiles TC, Ulleberg P, Landrø NI (2011). Verbal Memory Functions in Unipolar Major Depression with and Without Co-Morbid Anxiety. Clin Neuropsychol 1,1-17.
43. Mandelli L, Marino E, Pirovano A, Calati R, Zanardi R, Colombo C, Serretti A (2006). Improvement of cognitive functioning in mood disorder patients with depressive symptomatic recovery during treatment: An exploratory analysis. Psychiatry and Clinical Neurosciences 60, 5, 598-604.
44. Marazziti D, Consoli G, Picchetti M, Carlini M, Faravelli L (2010). Cognitive impairment in major depression. Eur J Pharmacol 10, 626, 1, 83-6.
45. Marin MF, Lord C, Andrews J, Juster RP, Sindi S, Arsenault- Lapierre G et al. (2011). Chronic stress, cognitive functioning and mental health. Neurobiol Learn Mem 2.
46. Martinez-Aran A, Vieta E, Torrent C, Sanchez-Moreno J, Goikolea JM, Salamero M, Malhi GS, Gonzalez-Pinto A, Daban C, Alvarez-Grandi S, Fountoulakis K, Kaprinis G, Tabares-Seisdedos R, Ayuso-Mateos JL (2007). Functional outcome in bipolar disorder: the role of clinical and cognitive factors. Bipolar Disord 9, 103-113.
47. McLennan SK, and Mathias JL (2009). The depression-executive dysfunction (DED) syndrome and response to antidepressants: a meta-analytic review. Int J Geriatric Psychiatry 25, 933-944.
48. Montgomery SA, Asberg M: A new depression scale designed to be sensitive to change (1979). British Journal of Psychiatry 134, 382-389.
49. Nelson HE (1982). The National Adult Reading Test (NART): test manual. NFER- Nelson.
50. Ochsner KN, Gross JJ (2008). Cognitive emotion regulation: insights from social cognitive and affective neuroscience. Currents Directions in Psychological Science 17, 1, 153-158.
51. Rantamaki T, Hendolin P, Kankaanpaa A, Mijatovic J, Piepponen P (2007). Pharmacologically diverse antidepressants rapidly activate brain-derived neurotrophic factor receptor TrkB and induce phospholipase-Cgamma signaling pathways in mouse brain. Neuropsychopharmacology 32, 2152-2162.
52. Raskin J, Wiltse CG, Siegal A, Sheikh J, Xu J, Dinkel J, Rotz BT, Mohs RC (2007). Efficacy of duloxetine on cognition and pain in elderly patients with major depressive disorder: an 8-week, double-blind, placebo-controlled trial. Am J Psychiatry 164, 6, 900-9.
53. Reitan RM, Davidson LA (1974). Clinical Neuropsychology: Current Status and Applications. John Wiley, New York.
54. Reitan RM (1955). The relation of the Trail Making Test to organic brain damage. Journal of Consulting Psychology 19, 393-394.
55. Reitan RM & Wolfson D (1993). The Halstead-Reitan Neuropsychological Test Battery: Theory and clinical interpretation (2nd ed). Neuropsychology Press, Tucson, AZ.
56. Reppemund S, Ising M, Lucae S, Zihl J (2009). Cognitive impairment in unipolar depression is persistent and nonspecific: further evidence for the final common pathway disorder hypothesis. Psychol Med 39, 4.
57. Risch N, Herrell R, Lehner T., Yee-Lang K, Eaves L, Hoh J, Griem A, Kovacs M, Ott J, Merikangas KR.(2009). Interaction Between the Serotonin Transporter Gene (5- HTTLPR), Stressful Life Events, and Risk of Depression. A Meta-analysis. JAMA 301, 23, 2462-2471.
58. Robins LN, Wing J, Wittchen HU, Farmer A., Jablonsky A, Pickens R, Regier DA, Sartorius N, Towle LH (1989). The Composite International Diagnostic interview: an epidemiologic instrument suitable for use in conjuction with different diagnostic systems and in different cultures. Archives of General Psychiatry 45, 1069-1077.
59. Robbinson TW, James M, Owen AM, Sahakian BJ, Micleness L, Rabitt P (1994). Cambridge Neuropsychological Test Automated Battery (CANTAB): a factor analytic study of a large sample of normal elderly volunteers. Dementia 5, 266-281
60. Sahakian BJ, Morris RG, Evenden JL, Heald A, Levy R, Philpot M et al. (1988). A copmparative study of visuospatial memory and learning in Alzheimer-type dementia and Parkinson's disease. Brain 111, 695-718.
61. Sarosi A, Gonda X, Balogh G, Szekely A, Sasvari M, Faludi G (2008). Gender differences in the neurocognitive components of depression. Neuropsychopharmacol Hung 10, 191-199.
62. Schmidt M (1996). Rey Auditory Verbal Learning Test: A Handbook. Western Psychological Services, Los Angeles, CA.
63. Seligman ME (1972). Learned helplessness. Annu Rev Med 23, 407-412.
64. Sheehan DV, Lecrubier Y, Sheehan KH et al. (1998). The MiniInternational Neuropsychiatric Interview (M.I.N.I.) the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. Journal of Clinical Psychiatry 59, 20, 22-33.
65. Sheline YI (2003). Neuroimaging studies of mood disorder effect on the brain. Biol Psychiatry 54, 338-352.
66. Smith A (1973). Symbol Digit Modalities Test. Western Psychological Services, Los Angeles, CA.
67. Spinnler H, Rognoni G (1987). Standardizzazione e taratura italiana di test neuropsicologici. Ital J Neurol Sci 6, Suppl. 8, 47-50.
68. Steffens DC, McQuoid DR, Krishnan KR (2002).The Duke Somatic Treatment Algorithm for Geriatric Depression (STAGED) approach. Psychopharmacol Bull 36, 2, 5868.
69. Story TJ, Potter GG, Attix DK, Welsh-Bohmer KA, Steffens DC (2008). Neurocognitive correlates of response to treatment in late-life depression. Am J Geriatr Psychiatry 16, 9, 7529.
70. Talarowska M, Florkowski A, Zboralski K, Berent D, Wierzbinski P, Galecki P (2010). Auditory-verbal declarative and operating memory among patients suffering from depressive disorders- preliminary study. Advances in Medical Sciences 55, 2, 317-327.
71. Thomas AJ, Gallagher P, Robinson LJ, Portera RJ, Young AH, Ferrier IN, O'Brien JT (2009). A comparison of neurocognitive impairment in younger and older adults with major depression.Psychol Med 39, 5,725-33.
72. Thorne DR, Genser SG, Sing HC et al. (1998). The Walter reed performance assessment battery. Nerobehav Toxicol Teratol 7, 415-418.
73. Uher et al. (2010). The moderation by the serotonin transporter gene of environmental adversity in the etiology of depression: 2009 update. Molecular Psychiatry 15, 18-22.
74. Yesavage JA, Brink TL, Rose TL, Lum O, Huang V, Adey M, Leirer O (1983). Development and validation of a geriatric depression screening: a preliminary report. J Psychiatr Res 17, 37-49
75. Young RC, Biggs JT, Ziegler VE, Meyer DA (1978). A rating scale for mania: reliability, validity and sensitivity. British Journal of Psychiatry 133, 429-435.
76. Ware JE, Sherbourne CD (1984). The MOS-36 items Short Form Health Survey (SF-36). Med Care 1992, 30, 473-483.
77. Wechsler D (1955). Manual for the Wechsler Adult Intelligence Scale (WAIS). Psychological Corporation, New York.
78. Wechsler D (1997). Wechsler Adult Intelligence Scale, Third Edition. The Psychological Corporation, San Antonio, TX.
79. Wise TN, Wiltse CG, losifescu DV, Sheridan M, Xu JY, Raskin J (2007). The safety and tolerability of duloxetine in depressed elderly patients with and without medical comorbidity. Int J Clin Pract 61, 8, 1283-93.